Recent Publications

• Lowery, E. G. & Thiele, T. E. (2010). Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS & Neurological Diseases - Drug Targets, 9, 77-86.

• Lowery, E. G., Spanos, M., Navarro, M., Lyons, A. M., Hodge, C. W., & Thiele, T. E. (2010). CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology, 35 1241-1252.

Cubero, I., Navarro, M., Carvajal, F., Lerma-Cabrera, J. M., & Thiele, T. E. (2010). Ethanol-induced increase of agouti-related protein (AgRP) immunoreactivity in the arcuate nucleus of the hypothalamus of C57BL/6J, but not 129/SvJ, inbred mice. Alcoholism: Clinical & Experimental Research, 34 693-701.

• Navarro, M., Cubero, I., Ko, L., & Thiele, T. E. (2009). Deletion of agouti-related protein blunts ethanol self-administration and binge-like drinking in mice. Genes, Brain, & Behavior, 8, 450-458.

Sparta, D. R., Ferraro III, F. M., Fee, J. R., Knapp, D. J., Breese, G. R., & Thiele, T. E. (2009). The alcohol deprivation effect (ADE) in C57BL/6J mice is observed using operant self-administration procedures and is modulated by CRF-1 receptor signaling. Alcoholism: Clinical & Experimental Research, 33, 31-42.

• Lyons, A. M., Lowery, E. G., Sparta, D. R., & Thiele, T. E. (2008). Effects of food availability and administration of orexigenic and anorectic agents on elevated ethanol drinking associated with drinking in the dark procedures. Alcoholism: Clinical & Experimental Research, 32, 1962-1968.

Navarro, M., Cubero, I., Knapp, D. J., Breese, G. R., & Thiele, T. E. (2008). Decreased immunoreactivity of the melanocortin neuropeptide a-melanocyte stimulating hormone (a-MSH) after chronic ethanol exposure in Sprague-Dawley rats. Alcoholism: Clinical & Experimental Research, 32, 266-276.

• Sparta, D. R., Sparrow, A. M., Lowery, E. G., Fee, J. R., Knapp, D. J., & Thiele, T. E. (2008). Blockade of the corticotropin releasing factor (CRF) type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcoholism: Clinical & Experimental Research, 32, 259-265.

Lowery, E. G., Sparrow, A. M., Breese, G. R., Knapp, D. J., & Thiele, T. E. (2008). The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcoholism: Clinical & Experimental Research,32, 240-248.

• Fee. J. R., Sparta, D. R., Picker, M. J., & Thiele, T. E. (2007). Corticotropin releasing factor (CRF)-1 receptor antagonist, CP-154,526, blocks the expression of ethanol-induced behavioral sensitization. Neuroscience, 150, 14-21.
  
  
• Sparta, D. R., Fee, J. R., Knapp, D. J., Breese, G. R., & Thiele, T. E. (2007). Elevated anxiety-like behavior following ethanol exposure in mutant mice lacking neuropeptide Y (NPY). Drug & Alcohol Dependence, 90, 297-300.

Click here for a more complete list of publications (PubMed)